Atrys Health Valuation
| ATRY Stock | EUR 3.14 0.11 3.38% |
At this time, the firm appears to be fairly valued. Atrys Health SL shows a prevailing Real Value of €3.22 per share. The current price of the firm is €3.14. Our model approximates the value of Atrys Health SL from analyzing the firm fundamentals such as Return On Equity of -0.0723, profit margin of (0.13) %, and Current Valuation of 647.57 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Atrys Health's price fluctuation is moderately volatile at this time. Calculation of the real value of Atrys Health SL is based on 3 months time horizon. Increasing Atrys Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Atrys Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Atrys Stock. However, Atrys Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.14 | Real 3.22 | Hype 3.14 | Naive 3.08 |
The real value of Atrys Stock, also known as its intrinsic value, is the underlying worth of Atrys Health SL Company, which is reflected in its stock price. It is based on Atrys Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Atrys Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Atrys Health SL helps investors to forecast how Atrys stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Atrys Health more accurately as focusing exclusively on Atrys Health's fundamentals will not take into account other important factors: Atrys Health Total Value Analysis
Atrys Health SL is presently forecasted to have takeover price of 647.57 M with market capitalization of 461.42 M, debt of 146.81 M, and cash on hands of 17.6 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Atrys Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
647.57 M | 461.42 M | 146.81 M | 17.6 M |
Atrys Health Investor Information
About 78.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. Atrys Health SL recorded a loss per share of 0.46. The entity had not issued any dividends in recent years. Atrys Health SL is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Atrys Health Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Atrys indicates not a very effective usage of assets in March.Atrys Health Ownership Allocation
Atrys Health holds a total of 75.89 Million outstanding shares. Atrys Health SL shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 78.47 percent of Atrys Health SL outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Atrys Health Profitability Analysis
The company reported the revenue of 121.01 M. Net Loss for the year was (23.25 M) with profit before overhead, payroll, taxes, and interest of 27.78 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Atrys Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Atrys Health and how it compares across the competition.
About Atrys Health Valuation
The stock valuation mechanism determines Atrys Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Atrys Health. We calculate exposure to Atrys Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Atrys Health's related companies.Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 525 people.
8 Steps to conduct Atrys Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Atrys Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Atrys Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Atrys Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Atrys Health's revenue streams: Identify Atrys Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Atrys Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Atrys Health's growth potential: Evaluate Atrys Health's management, business model, and growth potential.
- Determine Atrys Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Atrys Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Atrys Stock analysis
When running Atrys Health's price analysis, check to measure Atrys Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atrys Health is operating at the current time. Most of Atrys Health's value examination focuses on studying past and present price action to predict the probability of Atrys Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atrys Health's price. Additionally, you may evaluate how the addition of Atrys Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |